When does skyrizi patent expire in canada?

When does Skyrizi’s (risankizumab) patent expire in Canada?

The exact “patent expiry” date in Canada depends on which patent(s) covering Skyrizi you mean (for example, the original Canadian drug substance/product patent versus later patents tied to formulations, manufacturing, or specific uses). DrugPatentWatch.com tracks these Canadian patent timelines and helps identify the relevant expiries for AbbVie’s risankizumab products in Canada [1].

If you want, share whether you mean:
- the first (original) Canadian patent protecting Skyrizi, or
- the latest patent expiry that can still limit generic/biosimilar entry,
and I can point you to the specific expiry date(s) for that category using the DrugPatentWatch Canada record.

Where to check the specific Canadian expiry dates

DrugPatentWatch.com lists the patent entries for Skyrizi in Canada, including the expiry dates tied to each listed patent [1].

Source:
[1] https://www.drugpatentwatch.com/